Renato Costantini (pictured) is the new general counsel for Credit Suisse’s Swiss unit, where he will also be an executive board member of Credit Suisse and of the Swiss Universal Bank division’s management
Christian Haitz (pictured) will be the new General Counsel Corporate and M&A at Gategroup, one of the global leaders in airline catering, retail-on-board and hospitality products and services headquartered in Zurich. Haitz comes
Fedro sold its participation in Freesailors Coöperatief, the controlling shareholder of lastminute.com to Sterling Strategic Value Fund and a pool of private investors. In this context, the Swiss Takeover Board confirmed that the
Drägerwerk AG & Co. KGaA, an international operator in the fields of medical and safety technology, has acquired a majority stake in the Swiss-based start-up medical technology company STIMIT. VISCHER advised Stimit and the
by alessio foderi Legal iptiQ is part of Swiss Re Division Legal & Compliance. It was created in 2016 to support the iptiQ business, which is Swiss Re’s start-up division established to provide innovative retail
Crédit Agricole next bank (Suisse) successfully completed its second issuance under its Swiss Covered Bond Programme, issuing CHF 200 million Series 2021-1 0.125 per cent. Fixed-Rate Covered Bonds due April 2031 (with extended maturity date April 2032). The
Nexthink conducted a USD 180 million Series D financing round reaching a valuation of USD 1.1 billion. Nexthink is the leader in digital employee experience (DEX) management software. Permira, through its Growth Opportunities Fund, led the Series
Bär & Karrer advised Leoni AG – a leading German wire, cable and harnessing manufacturing group – on the sale of its subsidiary Leoni Schweiz AG to a consortium of buyers led by former board member
Lightrock, a leading global impact investor backed by LGT and the Princely House of Liechtenstein, announced its minority investment of 10% in South Pole Holding, one of the world’s largest companies fully focused on fighting
Vischer advised the sellers of Mestex AG on all legal issues related to the sale of their shares and stock options to the pharmaceutical company Grünenthal, a global operator in pain management and related
